Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,488,811
-
Share change
-
+1,979,453
-
Total reported value
-
$23,416,176
-
Put/Call ratio
-
46%
-
Price per share
-
$0.79
-
Number of holders
-
48
-
Value change
-
+$7,238,442
-
Number of buys
-
25
-
Number of sells
-
23
Institutional Holders of MAGENTA THERAPEUTICS INC - COM (MGTA) as of Q1 2023
As of 31 Mar 2023,
MAGENTA THERAPEUTICS INC - COM (MGTA) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,488,811 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, Lion Point Capital, LP, Atlas Venture Life Science Advisors, LLC, Alphabet Inc., Verition Fund Management LLC, VANGUARD GROUP INC, Western Standard LLC, TCW GROUP INC, ACADIAN ASSET MANAGEMENT LLC, and Laurion Capital Management LP.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.